Structural mimicry of UM171 and neomorphic cancer mutants co-opts E3 ligase KBTBD4 for HDAC1/2 recruitment

Neomorphic mutations and drugs can elicit unanticipated effects that require mechanistic understanding to inform clinical practice. Recurrent indel mutations in the Kelch domain of the KBTBD4 E3 ligase rewire epigenetic programs for stemness in medulloblastoma by recruiting LSD1-CoREST-HDAC1/2 compl...

Full description

Saved in:
Bibliographic Details
Published inNature communications Vol. 16; no. 1; pp. 3144 - 16
Main Authors Chen, Zhuoyao, Chi, Gamma, Balo, Timea, Chen, Xiangrong, Montes, Beatriz Ralsi, Clifford, Steven C., D’Angiolella, Vincenzo, Szabo, Timea, Kiss, Arpad, Novak, Tibor, Herner, András, Kotschy, András, Bullock, Alex N.
Format Journal Article
LanguageEnglish
Published London Nature Publishing Group UK 02.04.2025
Nature Publishing Group
Nature Portfolio
Subjects
Online AccessGet full text
ISSN2041-1723
2041-1723
DOI10.1038/s41467-025-58350-z

Cover

Abstract Neomorphic mutations and drugs can elicit unanticipated effects that require mechanistic understanding to inform clinical practice. Recurrent indel mutations in the Kelch domain of the KBTBD4 E3 ligase rewire epigenetic programs for stemness in medulloblastoma by recruiting LSD1-CoREST-HDAC1/2 complexes as neo-substrates for ubiquitination and degradation. UM171, an investigational drug for haematopoietic stem cell transplantation, was found to degrade LSD1-CoREST-HDAC1/2 complexes in a wild-type KBTBD4-dependent manner, suggesting a potential common mode of action. Here, we identify that these neomorphic interactions are mediated by the HDAC deacetylase domain. Cryo-EM studies of both wild-type and mutant KBTBD4 capture 2:1 and 2:2 KBTBD4-HDAC2 complexes, as well as a 2:1:1 KBTBD4-HDAC2-CoREST1 complex, at resolutions spanning 2.7 to 3.3 Å. The mutant and drug-induced complexes adopt similar structural assemblies requiring both Kelch domains in the KBTBD4 dimer for each HDAC2 interaction. UM171 is identified as a bona fide molecular glue binding across the ternary interface. Most strikingly, the indel mutation reshapes the same surface of KBTBD4 providing an example of a natural mimic of a molecular glue. Together, the structures provide mechanistic understanding of neomorphic KBTBD4, while structure-activity relationship (SAR) analysis of UM171 reveals analog S234984 as a more potent molecular glue for future studies. LSD1-CoREST-HDAC1/2 complexes are degraded by both the drug UM171 and cancer-associated mutations in the E3 ligase KBTBD4. Here, the authors use cryo-EM to demonstrate how these mutations and UM171 similarly alter KBTBD4 to recruit HDAC1/2, illustrating a natural example of a molecular glue.
AbstractList Neomorphic mutations and drugs can elicit unanticipated effects that require mechanistic understanding to inform clinical practice. Recurrent indel mutations in the Kelch domain of the KBTBD4 E3 ligase rewire epigenetic programs for stemness in medulloblastoma by recruiting LSD1-CoREST-HDAC1/2 complexes as neo-substrates for ubiquitination and degradation. UM171, an investigational drug for haematopoietic stem cell transplantation, was found to degrade LSD1-CoREST-HDAC1/2 complexes in a wild-type KBTBD4-dependent manner, suggesting a potential common mode of action. Here, we identify that these neomorphic interactions are mediated by the HDAC deacetylase domain. Cryo-EM studies of both wild-type and mutant KBTBD4 capture 2:1 and 2:2 KBTBD4-HDAC2 complexes, as well as a 2:1:1 KBTBD4-HDAC2-CoREST1 complex, at resolutions spanning 2.7 to 3.3 Å. The mutant and drug-induced complexes adopt similar structural assemblies requiring both Kelch domains in the KBTBD4 dimer for each HDAC2 interaction. UM171 is identified as a bona fide molecular glue binding across the ternary interface. Most strikingly, the indel mutation reshapes the same surface of KBTBD4 providing an example of a natural mimic of a molecular glue. Together, the structures provide mechanistic understanding of neomorphic KBTBD4, while structure-activity relationship (SAR) analysis of UM171 reveals analog S234984 as a more potent molecular glue for future studies.Neomorphic mutations and drugs can elicit unanticipated effects that require mechanistic understanding to inform clinical practice. Recurrent indel mutations in the Kelch domain of the KBTBD4 E3 ligase rewire epigenetic programs for stemness in medulloblastoma by recruiting LSD1-CoREST-HDAC1/2 complexes as neo-substrates for ubiquitination and degradation. UM171, an investigational drug for haematopoietic stem cell transplantation, was found to degrade LSD1-CoREST-HDAC1/2 complexes in a wild-type KBTBD4-dependent manner, suggesting a potential common mode of action. Here, we identify that these neomorphic interactions are mediated by the HDAC deacetylase domain. Cryo-EM studies of both wild-type and mutant KBTBD4 capture 2:1 and 2:2 KBTBD4-HDAC2 complexes, as well as a 2:1:1 KBTBD4-HDAC2-CoREST1 complex, at resolutions spanning 2.7 to 3.3 Å. The mutant and drug-induced complexes adopt similar structural assemblies requiring both Kelch domains in the KBTBD4 dimer for each HDAC2 interaction. UM171 is identified as a bona fide molecular glue binding across the ternary interface. Most strikingly, the indel mutation reshapes the same surface of KBTBD4 providing an example of a natural mimic of a molecular glue. Together, the structures provide mechanistic understanding of neomorphic KBTBD4, while structure-activity relationship (SAR) analysis of UM171 reveals analog S234984 as a more potent molecular glue for future studies.
Neomorphic mutations and drugs can elicit unanticipated effects that require mechanistic understanding to inform clinical practice. Recurrent indel mutations in the Kelch domain of the KBTBD4 E3 ligase rewire epigenetic programs for stemness in medulloblastoma by recruiting LSD1-CoREST-HDAC1/2 complexes as neo-substrates for ubiquitination and degradation. UM171, an investigational drug for haematopoietic stem cell transplantation, was found to degrade LSD1-CoREST-HDAC1/2 complexes in a wild-type KBTBD4-dependent manner, suggesting a potential common mode of action. Here, we identify that these neomorphic interactions are mediated by the HDAC deacetylase domain. Cryo-EM studies of both wild-type and mutant KBTBD4 capture 2:1 and 2:2 KBTBD4-HDAC2 complexes, as well as a 2:1:1 KBTBD4-HDAC2-CoREST1 complex, at resolutions spanning 2.7 to 3.3 Å. The mutant and drug-induced complexes adopt similar structural assemblies requiring both Kelch domains in the KBTBD4 dimer for each HDAC2 interaction. UM171 is identified as a bona fide molecular glue binding across the ternary interface. Most strikingly, the indel mutation reshapes the same surface of KBTBD4 providing an example of a natural mimic of a molecular glue. Together, the structures provide mechanistic understanding of neomorphic KBTBD4, while structure-activity relationship (SAR) analysis of UM171 reveals analog S234984 as a more potent molecular glue for future studies.
Neomorphic mutations and drugs can elicit unanticipated effects that require mechanistic understanding to inform clinical practice. Recurrent indel mutations in the Kelch domain of the KBTBD4 E3 ligase rewire epigenetic programs for stemness in medulloblastoma by recruiting LSD1-CoREST-HDAC1/2 complexes as neo-substrates for ubiquitination and degradation. UM171, an investigational drug for haematopoietic stem cell transplantation, was found to degrade LSD1-CoREST-HDAC1/2 complexes in a wild-type KBTBD4-dependent manner, suggesting a potential common mode of action. Here, we identify that these neomorphic interactions are mediated by the HDAC deacetylase domain. Cryo-EM studies of both wild-type and mutant KBTBD4 capture 2:1 and 2:2 KBTBD4-HDAC2 complexes, as well as a 2:1:1 KBTBD4-HDAC2-CoREST1 complex, at resolutions spanning 2.7 to 3.3 Å. The mutant and drug-induced complexes adopt similar structural assemblies requiring both Kelch domains in the KBTBD4 dimer for each HDAC2 interaction. UM171 is identified as a bona fide molecular glue binding across the ternary interface. Most strikingly, the indel mutation reshapes the same surface of KBTBD4 providing an example of a natural mimic of a molecular glue. Together, the structures provide mechanistic understanding of neomorphic KBTBD4, while structure-activity relationship (SAR) analysis of UM171 reveals analog S234984 as a more potent molecular glue for future studies.LSD1-CoREST-HDAC1/2 complexes are degraded by both the drug UM171 and cancer-associated mutations in the E3 ligase KBTBD4. Here, the authors use cryo-EM to demonstrate how these mutations and UM171 similarly alter KBTBD4 to recruit HDAC1/2, illustrating a natural example of a molecular glue.
Neomorphic mutations and drugs can elicit unanticipated effects that require mechanistic understanding to inform clinical practice. Recurrent indel mutations in the Kelch domain of the KBTBD4 E3 ligase rewire epigenetic programs for stemness in medulloblastoma by recruiting LSD1-CoREST-HDAC1/2 complexes as neo-substrates for ubiquitination and degradation. UM171, an investigational drug for haematopoietic stem cell transplantation, was found to degrade LSD1-CoREST-HDAC1/2 complexes in a wild-type KBTBD4-dependent manner, suggesting a potential common mode of action. Here, we identify that these neomorphic interactions are mediated by the HDAC deacetylase domain. Cryo-EM studies of both wild-type and mutant KBTBD4 capture 2:1 and 2:2 KBTBD4-HDAC2 complexes, as well as a 2:1:1 KBTBD4-HDAC2-CoREST1 complex, at resolutions spanning 2.7 to 3.3 Å. The mutant and drug-induced complexes adopt similar structural assemblies requiring both Kelch domains in the KBTBD4 dimer for each HDAC2 interaction. UM171 is identified as a bona fide molecular glue binding across the ternary interface. Most strikingly, the indel mutation reshapes the same surface of KBTBD4 providing an example of a natural mimic of a molecular glue. Together, the structures provide mechanistic understanding of neomorphic KBTBD4, while structure-activity relationship (SAR) analysis of UM171 reveals analog S234984 as a more potent molecular glue for future studies. LSD1-CoREST-HDAC1/2 complexes are degraded by both the drug UM171 and cancer-associated mutations in the E3 ligase KBTBD4. Here, the authors use cryo-EM to demonstrate how these mutations and UM171 similarly alter KBTBD4 to recruit HDAC1/2, illustrating a natural example of a molecular glue.
Abstract Neomorphic mutations and drugs can elicit unanticipated effects that require mechanistic understanding to inform clinical practice. Recurrent indel mutations in the Kelch domain of the KBTBD4 E3 ligase rewire epigenetic programs for stemness in medulloblastoma by recruiting LSD1-CoREST-HDAC1/2 complexes as neo-substrates for ubiquitination and degradation. UM171, an investigational drug for haematopoietic stem cell transplantation, was found to degrade LSD1-CoREST-HDAC1/2 complexes in a wild-type KBTBD4-dependent manner, suggesting a potential common mode of action. Here, we identify that these neomorphic interactions are mediated by the HDAC deacetylase domain. Cryo-EM studies of both wild-type and mutant KBTBD4 capture 2:1 and 2:2 KBTBD4-HDAC2 complexes, as well as a 2:1:1 KBTBD4-HDAC2-CoREST1 complex, at resolutions spanning 2.7 to 3.3 Å. The mutant and drug-induced complexes adopt similar structural assemblies requiring both Kelch domains in the KBTBD4 dimer for each HDAC2 interaction. UM171 is identified as a bona fide molecular glue binding across the ternary interface. Most strikingly, the indel mutation reshapes the same surface of KBTBD4 providing an example of a natural mimic of a molecular glue. Together, the structures provide mechanistic understanding of neomorphic KBTBD4, while structure-activity relationship (SAR) analysis of UM171 reveals analog S234984 as a more potent molecular glue for future studies.
ArticleNumber 3144
Author Chen, Xiangrong
Szabo, Timea
Chen, Zhuoyao
Montes, Beatriz Ralsi
Chi, Gamma
Kiss, Arpad
D’Angiolella, Vincenzo
Herner, András
Clifford, Steven C.
Novak, Tibor
Kotschy, András
Balo, Timea
Bullock, Alex N.
Author_xml – sequence: 1
  givenname: Zhuoyao
  orcidid: 0000-0003-4201-4649
  surname: Chen
  fullname: Chen, Zhuoyao
  organization: Centre for Medicines Discovery, University of Oxford
– sequence: 2
  givenname: Gamma
  orcidid: 0000-0001-9910-0965
  surname: Chi
  fullname: Chi, Gamma
  organization: Centre for Medicines Discovery, University of Oxford
– sequence: 3
  givenname: Timea
  orcidid: 0009-0009-4013-8243
  surname: Balo
  fullname: Balo, Timea
  organization: Servier Research Institute of Medicinal Chemistry, Hevesy György Ph.D. School of Chemistry, Eötvös Loránd University
– sequence: 4
  givenname: Xiangrong
  orcidid: 0000-0003-0587-3444
  surname: Chen
  fullname: Chen, Xiangrong
  organization: Centre for Medicines Discovery, University of Oxford
– sequence: 5
  givenname: Beatriz Ralsi
  surname: Montes
  fullname: Montes, Beatriz Ralsi
  organization: Centre for Medicines Discovery, University of Oxford
– sequence: 6
  givenname: Steven C.
  orcidid: 0000-0003-4893-2184
  surname: Clifford
  fullname: Clifford, Steven C.
  organization: Wolfson Childhood Cancer Research Centre, Newcastle University Centre for Cancer
– sequence: 7
  givenname: Vincenzo
  orcidid: 0000-0001-8365-9094
  surname: D’Angiolella
  fullname: D’Angiolella, Vincenzo
  organization: The Institute of Genetics and Cancer, University of Edinburgh, Crewe Road South
– sequence: 8
  givenname: Timea
  orcidid: 0000-0003-0700-4680
  surname: Szabo
  fullname: Szabo, Timea
  organization: Servier Research Institute of Medicinal Chemistry
– sequence: 9
  givenname: Arpad
  surname: Kiss
  fullname: Kiss, Arpad
  organization: Servier Research Institute of Medicinal Chemistry
– sequence: 10
  givenname: Tibor
  surname: Novak
  fullname: Novak, Tibor
  organization: Servier Research Institute of Medicinal Chemistry
– sequence: 11
  givenname: András
  orcidid: 0009-0005-1406-3971
  surname: Herner
  fullname: Herner, András
  organization: Servier Research Institute of Medicinal Chemistry
– sequence: 12
  givenname: András
  surname: Kotschy
  fullname: Kotschy, András
  organization: Servier Research Institute of Medicinal Chemistry
– sequence: 13
  givenname: Alex N.
  orcidid: 0000-0001-6757-0436
  surname: Bullock
  fullname: Bullock, Alex N.
  email: alex.bullock@cmd.ox.ac.uk
  organization: Centre for Medicines Discovery, University of Oxford
BackLink https://www.ncbi.nlm.nih.gov/pubmed/40175372$$D View this record in MEDLINE/PubMed
BookMark eNp9Uk1v1DAUtFARLUv_AAdkiQuXUH88x_EJtdtCK4o40J4tx7G3XiXxYidI7a_H3S2l5YAvz7Jnxs_z5jXaG-PoEHpLyUdKeHOUgUItK8JEJRouSHX3Ah0wArSikvG9J_t9dJjzmpTFFW0AXqF9IFQKLtkBWv-Y0mynOZkeD2EINt3i6PH1NyopNmOHRxeHmDY3wWJrRusSHubJjFPGNlZxU-oZx31Ymezw15Ork1PAPiZ8fnq8pEcMJ2fTHKbBjdMb9NKbPrvDh7pA15_Prpbn1eX3LxfL48vKgoKpahvBSdtJR30HRijWgiUAHsAqwTrvKAMQrW8VY9Q4abmpQUjTWG65B8UX6GKn20Wz1psUBpNudTRBbw9iWmmTpmB7pxVzTlKQbc0UtNwYqlrjlW89I03dyaL1aae1mdvBdbZ8ozj1TPT5zRhu9Cr-0pSqWhSbi8KHB4UUf84uT3oI2bq-N8XZOWtOGyGbWpZ5LND7f6DrOKexeLVFCcIUuUe9e9rSYy9_ZloAbAewKeacnH-EUKLvs6N32dElO3qbHX1XSHxHygU8rlz6-_Z_WL8BLZ3E9Q
Cites_doi 10.1016/j.celrep.2020.01.091
10.1016/j.molcel.2013.05.020
10.1182/bloodadvances.2023010599
10.1016/j.sbi.2011.08.004
10.1038/s41580-024-00729-9
10.1016/j.cell.2022.04.014
10.1107/S0907444904019158
10.1016/S2352-3026(19)30202-9
10.1002/iub.504
10.1016/j.sbi.2019.01.004
10.1093/nar/gkaa1121
10.1038/s41598-018-32927-9
10.1016/j.jbc.2023.104662
10.1016/j.freeradbiomed.2015.05.034
10.1038/s44320-024-00055-4
10.1016/j.molcel.2006.01.013
10.1038/s41467-022-28507-1
10.1074/jbc.M112.437996
10.1016/j.str.2019.06.005
10.1007/s11060-023-04310-w
10.21037/sci-2023-016
10.1038/nature13527
10.1016/j.molcel.2006.07.012
10.1016/j.chembiol.2024.05.004
10.1074/jbc.M113.490706
10.1016/j.chembiol.2021.04.009
10.7554/eLife.59994
10.1021/acs.biochem.6b01014
10.1038/s41586-024-08533-3
10.1107/S2059798319011471
10.1038/s41467-024-48045-2
10.1038/s41589-023-01409-z
10.1126/science.aal3755
10.1038/s41418-022-00983-4
10.1002/jcc.20084
10.1007/s00401-019-01990-5
10.1038/s41419-024-06565-1
10.1126/science.1256337
10.1093/jmcb/mjy021
10.1098/rsob.200041
10.1038/s41594-020-0405-9
10.1073/pnas.95.21.12123
10.1038/s41467-021-23609-8
10.1016/j.stem.2020.12.002
10.1038/nature22973
10.1042/BJ20140153
10.1038/onc.2016.312
10.1016/j.molcel.2009.09.022
10.1021/jm701079h
10.1016/j.cell.2008.07.022
10.1038/nature08617
10.1038/s41594-023-01182-6
10.1038/sj.emboj.7601243
10.1038/s41586-020-2374-x
10.1016/j.str.2023.09.002
10.1038/s41586-024-08532-4
10.1182/blood.2020005827
10.1038/s41586-021-03819-2
10.1126/science.aat0572
ContentType Journal Article
Copyright The Author(s) 2025
2025. The Author(s).
Copyright Nature Publishing Group 2025
The Author(s) 2025 2025
Copyright_xml – notice: The Author(s) 2025
– notice: 2025. The Author(s).
– notice: Copyright Nature Publishing Group 2025
– notice: The Author(s) 2025 2025
DBID C6C
AAYXX
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
3V.
7QL
7QP
7QR
7SN
7SS
7ST
7T5
7T7
7TM
7TO
7X7
7XB
88E
8AO
8FD
8FE
8FG
8FH
8FI
8FJ
8FK
ABUWG
AEUYN
AFKRA
ARAPS
AZQEC
BBNVY
BENPR
BGLVJ
BHPHI
C1K
CCPQU
DWQXO
FR3
FYUFA
GHDGH
GNUQQ
H94
HCIFZ
K9.
LK8
M0S
M1P
M7P
P5Z
P62
P64
PHGZM
PHGZT
PIMPY
PJZUB
PKEHL
PPXIY
PQEST
PQGLB
PQQKQ
PQUKI
PRINS
RC3
SOI
7X8
5PM
DOA
DOI 10.1038/s41467-025-58350-z
DatabaseName Springer Nature OA Free Journals
CrossRef
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
ProQuest Central (Corporate)
Bacteriology Abstracts (Microbiology B)
Calcium & Calcified Tissue Abstracts
Chemoreception Abstracts
Ecology Abstracts
Entomology Abstracts (Full archive)
Environment Abstracts
Immunology Abstracts
Industrial and Applied Microbiology Abstracts (Microbiology A)
Nucleic Acids Abstracts
Oncogenes and Growth Factors Abstracts
Health & Medical Collection
ProQuest Central (purchase pre-March 2016)
Medical Database (Alumni Edition)
ProQuest Pharma Collection
Technology Research Database
ProQuest SciTech Collection
ProQuest Technology Collection
ProQuest Natural Science Collection
Hospital Premium Collection
Hospital Premium Collection (Alumni Edition)
ProQuest Central (Alumni) (purchase pre-March 2016)
ProQuest Central (Alumni)
ProQuest One Sustainability
ProQuest Central UK/Ireland
Health Research Premium Collection
ProQuest Central Essentials
Biological Science Collection (subscription)
ProQuest Central
Technology Collection
Natural Science Collection
Environmental Sciences and Pollution Management
ProQuest One
ProQuest Central
Engineering Research Database
Proquest Health Research Premium Collection
Health Research Premium Collection (Alumni)
ProQuest Central Student
AIDS and Cancer Research Abstracts
SciTech Premium Collection
ProQuest Health & Medical Complete (Alumni)
Biological Sciences
ProQuest Health & Medical Collection
Medical Database
Biological Science Database
Advanced Technologies & Aerospace Database
ProQuest Advanced Technologies & Aerospace Collection
Biotechnology and BioEngineering Abstracts
Proquest Central Premium
ProQuest One Academic (New)
Publicly Available Content Database
ProQuest Health & Medical Research Collection
ProQuest One Academic Middle East (New)
ProQuest One Health & Nursing
ProQuest One Academic Eastern Edition (DO NOT USE)
ProQuest One Applied & Life Sciences
ProQuest One Academic
ProQuest One Academic UKI Edition
ProQuest Central China
Genetics Abstracts
Environment Abstracts
MEDLINE - Academic
PubMed Central (Full Participant titles)
DOAJ Directory of Open Access Journals
DatabaseTitle CrossRef
MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
Publicly Available Content Database
ProQuest Central Student
Oncogenes and Growth Factors Abstracts
ProQuest Advanced Technologies & Aerospace Collection
ProQuest Central Essentials
Nucleic Acids Abstracts
SciTech Premium Collection
ProQuest Central China
Environmental Sciences and Pollution Management
ProQuest One Applied & Life Sciences
ProQuest One Sustainability
Health Research Premium Collection
Natural Science Collection
Health & Medical Research Collection
Biological Science Collection
Chemoreception Abstracts
Industrial and Applied Microbiology Abstracts (Microbiology A)
ProQuest Central (New)
ProQuest Medical Library (Alumni)
Advanced Technologies & Aerospace Collection
ProQuest Biological Science Collection
ProQuest One Academic Eastern Edition
ProQuest Hospital Collection
ProQuest Technology Collection
Health Research Premium Collection (Alumni)
Biological Science Database
Ecology Abstracts
ProQuest Hospital Collection (Alumni)
Biotechnology and BioEngineering Abstracts
Entomology Abstracts
ProQuest Health & Medical Complete
ProQuest One Academic UKI Edition
Engineering Research Database
ProQuest One Academic
Calcium & Calcified Tissue Abstracts
ProQuest One Academic (New)
Technology Collection
Technology Research Database
ProQuest One Academic Middle East (New)
ProQuest Health & Medical Complete (Alumni)
ProQuest Central (Alumni Edition)
ProQuest One Community College
ProQuest One Health & Nursing
ProQuest Natural Science Collection
ProQuest Pharma Collection
ProQuest Central
ProQuest Health & Medical Research Collection
Genetics Abstracts
Health and Medicine Complete (Alumni Edition)
ProQuest Central Korea
Bacteriology Abstracts (Microbiology B)
AIDS and Cancer Research Abstracts
ProQuest SciTech Collection
Advanced Technologies & Aerospace Database
ProQuest Medical Library
Immunology Abstracts
Environment Abstracts
ProQuest Central (Alumni)
MEDLINE - Academic
DatabaseTitleList MEDLINE - Academic
CrossRef
Publicly Available Content Database


MEDLINE

Database_xml – sequence: 1
  dbid: C6C
  name: Springer Nature OA Free Journals
  url: http://www.springeropen.com/
  sourceTypes: Publisher
– sequence: 2
  dbid: DOA
  name: DOAJ Directory of Open Access Journals
  url: https://www.doaj.org/
  sourceTypes: Open Website
– sequence: 3
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 4
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
– sequence: 5
  dbid: 8FG
  name: ProQuest Technology Collection
  url: https://search.proquest.com/technologycollection1
  sourceTypes: Aggregation Database
DeliveryMethod fulltext_linktorsrc
Discipline Biology
EISSN 2041-1723
EndPage 16
ExternalDocumentID oai_doaj_org_article_92ee7147b6294b3aa19baf9fbf2086d7
PMC11965401
40175372
10_1038_s41467_025_58350_z
Genre Journal Article
GrantInformation_xml – fundername: Cancer Research UK (CRUK)
  grantid: DRCNPG-May21\100002
  funderid: https://doi.org/10.13039/501100000289
– fundername: Gedeon Richter
  funderid: https://doi.org/10.13039/501100003358
– fundername: Innovative Medicines Initiative (IMI)
  grantid: 875510
  funderid: https://doi.org/10.13039/501100010767
– fundername: Cancer Research UK (CRUK)
  grantid: DRCNPG-May21\100002
– fundername: Innovative Medicines Initiative (IMI)
  grantid: 875510
– fundername: Wellcome Trust
GroupedDBID ---
0R~
39C
53G
5VS
70F
7X7
88E
8AO
8FE
8FG
8FH
8FI
8FJ
AAHBH
AAJSJ
AASML
ABUWG
ACGFO
ACGFS
ACIWK
ACMJI
ACPRK
ADBBV
ADFRT
ADMLS
ADRAZ
AENEX
AEUYN
AFKRA
AFRAH
AHMBA
AJTQC
ALIPV
ALMA_UNASSIGNED_HOLDINGS
AMTXH
AOIJS
ARAPS
ASPBG
AVWKF
AZFZN
BBNVY
BCNDV
BENPR
BGLVJ
BHPHI
BPHCQ
BVXVI
C6C
CCPQU
DIK
EBLON
EBS
EE.
EMOBN
F5P
FEDTE
FYUFA
GROUPED_DOAJ
HCIFZ
HMCUK
HVGLF
HYE
HZ~
KQ8
LGEZI
LK8
LOTEE
M1P
M7P
M~E
NADUK
NAO
NXXTH
O9-
OK1
P2P
P62
PHGZT
PIMPY
PQQKQ
PROAC
PSQYO
RNS
RNT
RNTTT
RPM
SNYQT
SV3
TSG
UKHRP
AAYXX
CITATION
PHGZM
CGR
CUY
CVF
ECM
EIF
NPM
3V.
7QL
7QP
7QR
7SN
7SS
7ST
7T5
7T7
7TM
7TO
7XB
8FD
8FK
AZQEC
C1K
DWQXO
FR3
GNUQQ
H94
K9.
M48
P64
PJZUB
PKEHL
PPXIY
PQEST
PQGLB
PQUKI
PRINS
RC3
SOI
7X8
PUEGO
5PM
ID FETCH-LOGICAL-c494t-b8530bd7e1fd4a592b4c044f44c952dfe12445bfb9221ae7c3a6457a8c3c3f493
IEDL.DBID C6C
ISSN 2041-1723
IngestDate Wed Aug 27 01:24:50 EDT 2025
Thu Aug 21 18:38:42 EDT 2025
Fri Sep 05 17:45:29 EDT 2025
Sat Aug 23 12:31:10 EDT 2025
Sat May 17 01:30:13 EDT 2025
Tue Jul 01 05:11:58 EDT 2025
Thu Apr 03 03:05:22 EDT 2025
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 1
Language English
License 2025. The Author(s).
Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c494t-b8530bd7e1fd4a592b4c044f44c952dfe12445bfb9221ae7c3a6457a8c3c3f493
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 14
content type line 23
ORCID 0000-0001-9910-0965
0000-0003-4893-2184
0000-0003-4201-4649
0009-0009-4013-8243
0000-0001-6757-0436
0009-0005-1406-3971
0000-0003-0700-4680
0000-0001-8365-9094
0000-0003-0587-3444
OpenAccessLink https://www.nature.com/articles/s41467-025-58350-z
PMID 40175372
PQID 3185502905
PQPubID 546298
PageCount 16
ParticipantIDs doaj_primary_oai_doaj_org_article_92ee7147b6294b3aa19baf9fbf2086d7
pubmedcentral_primary_oai_pubmedcentral_nih_gov_11965401
proquest_miscellaneous_3185786775
proquest_journals_3185502905
pubmed_primary_40175372
crossref_primary_10_1038_s41467_025_58350_z
springer_journals_10_1038_s41467_025_58350_z
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate 2025-04-02
PublicationDateYYYYMMDD 2025-04-02
PublicationDate_xml – month: 04
  year: 2025
  text: 2025-04-02
  day: 02
PublicationDecade 2020
PublicationPlace London
PublicationPlace_xml – name: London
– name: England
PublicationTitle Nature communications
PublicationTitleAbbrev Nat Commun
PublicationTitleAlternate Nat Commun
PublicationYear 2025
Publisher Nature Publishing Group UK
Nature Publishing Group
Nature Portfolio
Publisher_xml – name: Nature Publishing Group UK
– name: Nature Publishing Group
– name: Nature Portfolio
References KF Ahmad (58350_CR31) 1998; 95
SC Lo (58350_CR40) 2006; 25
K Zemaitis (58350_CR24) 2023; 299
Z Kozicka (58350_CR50) 2021; 28
S Cohen (58350_CR21) 2020; 7
B Padmanabhan (58350_CR39) 2006; 21
ME Matyskiela (58350_CR9) 2020; 27
I Fares (58350_CR19) 2014; 345
S Cao (58350_CR48) 2022; 13
J Chagraoui (58350_CR23) 2021; 28
Y Deng (58350_CR54) 2024; 15
V Takiar (58350_CR2) 2017; 36
RDW Kelly (58350_CR42) 2018; 8
SL Schreiber (58350_CR5) 2024; 31
P Canning (58350_CR30) 2013; 288
D Liebschner (58350_CR59) 2019; 75
CJ Millard (58350_CR29) 2013; 51
EF Pettersen (58350_CR57) 2004; 25
J Jumper (58350_CR56) 2021; 596
P Emsley (58350_CR58) 2004; 60
S Bastani (58350_CR18) 2023; 10
JC Lee (58350_CR16) 2019; 137
M Slabicki (58350_CR12) 2020; 585
M Yang (58350_CR26) 2006; 23
W Wang (58350_CR34) 2024; 15
X Mo (58350_CR3) 2022; 185
PA Northcott (58350_CR15) 2017; 547
OM Moradei (58350_CR46) 2007; 50
A Subramaniam (58350_CR22) 2020; 136
BE Lauffer (58350_CR47) 2013; 288
Z Chen (58350_CR37) 2020; 10
CJ Jeffery (58350_CR1) 2011; 63
S Yamashita (58350_CR17) 2023; 162
CJ Millard (58350_CR51) 2020; 48
P Canning (58350_CR35) 2015; 88
ES Fischer (58350_CR8) 2014; 512
M Zhuang (58350_CR27) 2009; 36
NJ Porter (58350_CR45) 2019; 59
S Cohen (58350_CR20) 2023; 7
Z Chen (58350_CR36) 2019; 27
L Dang (58350_CR7) 2009; 462
Y Yang (58350_CR28) 2018; 10
Z Chen (58350_CR14) 2022; 29
Z Kozicka (58350_CR49) 2024; 20
Y Song (58350_CR25) 2020; 30
DM Duda (58350_CR55) 2008; 134
58350_CR13
FR Schumacher (58350_CR38) 2014; 460
Y Hu (58350_CR32) 2024; 31
58350_CR53
58350_CR52
58350_CR11
58350_CR10
P Hosseinzadeh (58350_CR43) 2021; 12
NJ Porter (58350_CR44) 2016; 55
58350_CR4
PM Lombardi (58350_CR41) 2011; 21
58350_CR6
F Teng (58350_CR33) 2023; 31
References_xml – volume: 30
  start-page: 2699
  year: 2020
  ident: 58350_CR25
  publication-title: Cell Rep.
  doi: 10.1016/j.celrep.2020.01.091
– volume: 51
  start-page: 57
  year: 2013
  ident: 58350_CR29
  publication-title: Mol. Cell
  doi: 10.1016/j.molcel.2013.05.020
– volume: 7
  start-page: 5717
  year: 2023
  ident: 58350_CR20
  publication-title: Blood Adv.
  doi: 10.1182/bloodadvances.2023010599
– volume: 21
  start-page: 735
  year: 2011
  ident: 58350_CR41
  publication-title: Curr. Opin. Struct. Biol.
  doi: 10.1016/j.sbi.2011.08.004
– ident: 58350_CR6
  doi: 10.1038/s41580-024-00729-9
– volume: 185
  start-page: 1974
  year: 2022
  ident: 58350_CR3
  publication-title: Cell
  doi: 10.1016/j.cell.2022.04.014
– volume: 60
  start-page: 2126
  year: 2004
  ident: 58350_CR58
  publication-title: Acta Crystallogr D. Biol. Crystallogr
  doi: 10.1107/S0907444904019158
– volume: 7
  start-page: e134
  year: 2020
  ident: 58350_CR21
  publication-title: Lancet Haematol.
  doi: 10.1016/S2352-3026(19)30202-9
– volume: 63
  start-page: 489
  year: 2011
  ident: 58350_CR1
  publication-title: IUBMB Life
  doi: 10.1002/iub.504
– volume: 59
  start-page: 9
  year: 2019
  ident: 58350_CR45
  publication-title: Curr. Opin. Struct. Biol.
  doi: 10.1016/j.sbi.2019.01.004
– volume: 48
  start-page: 12972
  year: 2020
  ident: 58350_CR51
  publication-title: Nucleic Acids Res
  doi: 10.1093/nar/gkaa1121
– volume: 8
  year: 2018
  ident: 58350_CR42
  publication-title: Sci. Rep.
  doi: 10.1038/s41598-018-32927-9
– volume: 299
  start-page: 104662
  year: 2023
  ident: 58350_CR24
  publication-title: J. Biol. Chem.
  doi: 10.1016/j.jbc.2023.104662
– volume: 88
  start-page: 101
  year: 2015
  ident: 58350_CR35
  publication-title: Free Radic. Biol. Med
  doi: 10.1016/j.freeradbiomed.2015.05.034
– ident: 58350_CR4
  doi: 10.1038/s44320-024-00055-4
– volume: 21
  start-page: 689
  year: 2006
  ident: 58350_CR39
  publication-title: Mol. Cell
  doi: 10.1016/j.molcel.2006.01.013
– volume: 13
  year: 2022
  ident: 58350_CR48
  publication-title: Nat. Commun.
  doi: 10.1038/s41467-022-28507-1
– volume: 288
  start-page: 7803
  year: 2013
  ident: 58350_CR30
  publication-title: J. Biol. Chem.
  doi: 10.1074/jbc.M112.437996
– volume: 27
  start-page: 1395
  year: 2019
  ident: 58350_CR36
  publication-title: Structure
  doi: 10.1016/j.str.2019.06.005
– volume: 162
  start-page: 425
  year: 2023
  ident: 58350_CR17
  publication-title: J. Neurooncol
  doi: 10.1007/s11060-023-04310-w
– volume: 10
  start-page: 15
  year: 2023
  ident: 58350_CR18
  publication-title: Stem Cell Investig.
  doi: 10.21037/sci-2023-016
– volume: 512
  start-page: 49
  year: 2014
  ident: 58350_CR8
  publication-title: Nature
  doi: 10.1038/nature13527
– volume: 23
  start-page: 377
  year: 2006
  ident: 58350_CR26
  publication-title: Mol. Cell
  doi: 10.1016/j.molcel.2006.07.012
– volume: 31
  start-page: 1050
  year: 2024
  ident: 58350_CR5
  publication-title: Cell Chem. Biol.
  doi: 10.1016/j.chembiol.2024.05.004
– volume: 288
  start-page: 26926
  year: 2013
  ident: 58350_CR47
  publication-title: J. Biol. Chem.
  doi: 10.1074/jbc.M113.490706
– volume: 28
  start-page: 1032
  year: 2021
  ident: 58350_CR50
  publication-title: Cell Chem. Biol.
  doi: 10.1016/j.chembiol.2021.04.009
– ident: 58350_CR13
  doi: 10.7554/eLife.59994
– volume: 55
  start-page: 6718
  year: 2016
  ident: 58350_CR44
  publication-title: Biochemistry
  doi: 10.1021/acs.biochem.6b01014
– ident: 58350_CR53
  doi: 10.1038/s41586-024-08533-3
– volume: 75
  start-page: 861
  year: 2019
  ident: 58350_CR59
  publication-title: Acta Crystallogr D. Struct. Biol.
  doi: 10.1107/S2059798319011471
– volume: 15
  year: 2024
  ident: 58350_CR34
  publication-title: Nat. Commun.
  doi: 10.1038/s41467-024-48045-2
– volume: 20
  start-page: 93
  year: 2024
  ident: 58350_CR49
  publication-title: Nat. Chem. Biol.
  doi: 10.1038/s41589-023-01409-z
– ident: 58350_CR11
  doi: 10.1126/science.aal3755
– volume: 29
  start-page: 1955
  year: 2022
  ident: 58350_CR14
  publication-title: Cell Death Differ.
  doi: 10.1038/s41418-022-00983-4
– volume: 25
  start-page: 1605
  year: 2004
  ident: 58350_CR57
  publication-title: J. Comput Chem.
  doi: 10.1002/jcc.20084
– volume: 137
  start-page: 851
  year: 2019
  ident: 58350_CR16
  publication-title: Acta Neuropathol.
  doi: 10.1007/s00401-019-01990-5
– volume: 15
  year: 2024
  ident: 58350_CR54
  publication-title: Cell Death Dis.
  doi: 10.1038/s41419-024-06565-1
– volume: 345
  start-page: 1509
  year: 2014
  ident: 58350_CR19
  publication-title: Science
  doi: 10.1126/science.1256337
– volume: 10
  start-page: 285
  year: 2018
  ident: 58350_CR28
  publication-title: J. Mol. Cell Biol.
  doi: 10.1093/jmcb/mjy021
– volume: 10
  start-page: 200041
  year: 2020
  ident: 58350_CR37
  publication-title: Open Biol.
  doi: 10.1098/rsob.200041
– volume: 27
  start-page: 319
  year: 2020
  ident: 58350_CR9
  publication-title: Nat. Struct. Mol. Biol.
  doi: 10.1038/s41594-020-0405-9
– volume: 95
  start-page: 12123
  year: 1998
  ident: 58350_CR31
  publication-title: Proc. Natl Acad. Sci. USA
  doi: 10.1073/pnas.95.21.12123
– volume: 12
  year: 2021
  ident: 58350_CR43
  publication-title: Nat. Commun.
  doi: 10.1038/s41467-021-23609-8
– volume: 28
  start-page: 48
  year: 2021
  ident: 58350_CR23
  publication-title: Cell Stem Cell
  doi: 10.1016/j.stem.2020.12.002
– volume: 547
  start-page: 311
  year: 2017
  ident: 58350_CR15
  publication-title: Nature
  doi: 10.1038/nature22973
– volume: 460
  start-page: 237
  year: 2014
  ident: 58350_CR38
  publication-title: Biochem J.
  doi: 10.1042/BJ20140153
– volume: 36
  start-page: 1607
  year: 2017
  ident: 58350_CR2
  publication-title: Oncogene
  doi: 10.1038/onc.2016.312
– volume: 36
  start-page: 39
  year: 2009
  ident: 58350_CR27
  publication-title: Mol. Cell
  doi: 10.1016/j.molcel.2009.09.022
– volume: 50
  start-page: 5543
  year: 2007
  ident: 58350_CR46
  publication-title: J. Med Chem.
  doi: 10.1021/jm701079h
– volume: 134
  start-page: 995
  year: 2008
  ident: 58350_CR55
  publication-title: Cell
  doi: 10.1016/j.cell.2008.07.022
– volume: 462
  start-page: 739
  year: 2009
  ident: 58350_CR7
  publication-title: Nature
  doi: 10.1038/nature08617
– volume: 31
  start-page: 336
  year: 2024
  ident: 58350_CR32
  publication-title: Nat. Struct. Mol. Biol.
  doi: 10.1038/s41594-023-01182-6
– volume: 25
  start-page: 3605
  year: 2006
  ident: 58350_CR40
  publication-title: EMBO J.
  doi: 10.1038/sj.emboj.7601243
– volume: 585
  start-page: 293
  year: 2020
  ident: 58350_CR12
  publication-title: Nature
  doi: 10.1038/s41586-020-2374-x
– volume: 31
  start-page: 1431
  year: 2023
  ident: 58350_CR33
  publication-title: Structure
  doi: 10.1016/j.str.2023.09.002
– ident: 58350_CR52
  doi: 10.1038/s41586-024-08532-4
– volume: 136
  start-page: 2151
  year: 2020
  ident: 58350_CR22
  publication-title: Blood
  doi: 10.1182/blood.2020005827
– volume: 596
  start-page: 583
  year: 2021
  ident: 58350_CR56
  publication-title: Nature
  doi: 10.1038/s41586-021-03819-2
– ident: 58350_CR10
  doi: 10.1126/science.aat0572
SSID ssj0000391844
Score 2.4720614
Snippet Neomorphic mutations and drugs can elicit unanticipated effects that require mechanistic understanding to inform clinical practice. Recurrent indel mutations...
Abstract Neomorphic mutations and drugs can elicit unanticipated effects that require mechanistic understanding to inform clinical practice. Recurrent indel...
SourceID doaj
pubmedcentral
proquest
pubmed
crossref
springer
SourceType Open Website
Open Access Repository
Aggregation Database
Index Database
Publisher
StartPage 3144
SubjectTerms 101/28
13/1
13/106
13/109
13/44
14/1
631/45/474/2073
631/45/535/1258/1259
631/67/395
631/80/304
631/92/613
82/16
82/29
82/58
82/80
9/10
Cancer
Co-Repressor Proteins - genetics
Co-Repressor Proteins - metabolism
Cryoelectron Microscopy
Epigenetics
HDAC2 protein
Hematopoietic stem cells
Histone deacetylase
Histone Deacetylase 1 - chemistry
Histone Deacetylase 1 - genetics
Histone Deacetylase 1 - metabolism
Histone Deacetylase 2 - chemistry
Histone Deacetylase 2 - genetics
Histone Deacetylase 2 - metabolism
Humanities and Social Sciences
Humans
Immunosuppressive agents
Medulloblastoma
Mimicry
Mode of action
multidisciplinary
Mutants
Mutation
Protein Binding
Science
Science (multidisciplinary)
Stem cell transplantation
Stem cells
Ubiquitin-protein ligase
Ubiquitin-Protein Ligases - chemistry
Ubiquitin-Protein Ligases - genetics
Ubiquitin-Protein Ligases - metabolism
Ubiquitination
SummonAdditionalLinks – databaseName: DOAJ Directory of Open Access Journals
  dbid: DOA
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1La9wwEBYlUOil9F23SVGht9asLY0s65jNg6UlvTQLuQlJllqXrh12s4fk12cke7fZPuilJ4M9hmHeg0bfEPLOYc7yVUDjNYLnUDeAcTC4vEJ6ZjE_q7Ql4uxzNZvDxwtxcWfVV5wJG-CBB8FNFPNeliBtxRRYbkyprAkq2MCwGm_SPfJCFXeaqRSDucLWBcZbMgWvJytIMSFubxVYdRT5zU4mSoD9f6oyfx-W_OXENCWi00fk4VhB0sOB88fknu-ekPvDTsnrp-T7l4QIG9E06KJdtG55TftA52elLKnpGtr5ftGjdFtHXVT5ki7WcZXwiro-7y_xecLpj_Yrpjf6aXo-PQaKhS2dHR8elRNGMUIu122aTX9G5qcn50ezfFyokDtQcJVbzM2FbaQvQwNGKFSGKwACgFOCNcHHZC9ssIqx0njpuKlASFM77ngAxZ-Tva7v_EtCPXo6Z8Y1FTNgAVvymjceIoSTc5I1GXm_Ea6-HHAzdDrv5rUeVKFRFTqpQt9kZBrlv6WMmNfpBVqCHi1B_8sSMrK_0Z4eHXGl4-VwUTBViIy83X5GF4rnIgYlvh5oZMT1Q5oXg7K3nGD7iQ2dZBmpd8xgh9XdL137LcF0lxGsEf_PyIeNxfzk6--yePU_ZPGaPGDR1OOIEdsne2h5_gCrpyv7JjnKLemIFRc
  priority: 102
  providerName: Directory of Open Access Journals
– databaseName: Health & Medical Collection
  dbid: 7X7
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV3Nb9MwFLdgCIkL4puMgYzEDaIm9kscn9C6D1WgcWGVerNsx96CaNK162H763l20k7l6xQpdiTnfT_7-fcI-WDRZ7nSo_DqgqdQ1YB20Nu0xPnMoH-WsUvE2bdyMoUvs2I2bLithrLKjU2MhrrubNgjH4VbvkXGZFZ8XlyloWtUOF0dWmjcJw9yjERC6wYxE9s9loB-XgEMd2UyXo1WEC1D6OFaYOyRpbc7_ijC9v8t1vyzZPK3c9Pojk6fkMdDHEkPe8Y_Jfdc-4w87DtL3jwnP75HXNiAqUHnzbyxyxvaeTo9y0VOdVvT1nXzDmncWGoD45d0vg4NhVfUdmm3wOcJpz-bC3Ry9Ov4fHwMFMNbOjk-PMpHjKKdXK6bWKH-gkxPT86PJunQViG1IOE6NeihM1MLl_sadCGRJTYD8ABWFqz2Lrj8wngjGcu1E5brEgqhK8st9yD5S7LXdq17TahDfedM27pkGgxgYl7x2kEAcrJWsDohHzfEVYsePUPFU29eqZ4VClmhIivUbULGgf7bmQH5Or7olhdqUCQlmXMiB2FKJsFwrXNptJfeeIbZWS0ScrDhnhrUcaXuhCch77fDqEjhdEQjxdf9HBHQ_XDOq57Z25VgEoppnWAJqXbEYGepuyNtcxnBuvMA2YjfJ-TTRmLu1vVvWuz__zfekEcsCHEoIWIHZA9lyr3F6OjavIsq8AvNRAv_
  priority: 102
  providerName: ProQuest
Title Structural mimicry of UM171 and neomorphic cancer mutants co-opts E3 ligase KBTBD4 for HDAC1/2 recruitment
URI https://link.springer.com/article/10.1038/s41467-025-58350-z
https://www.ncbi.nlm.nih.gov/pubmed/40175372
https://www.proquest.com/docview/3185502905
https://www.proquest.com/docview/3185786775
https://pubmed.ncbi.nlm.nih.gov/PMC11965401
https://doaj.org/article/92ee7147b6294b3aa19baf9fbf2086d7
Volume 16
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwlV3da9swEBf9YLCXse9564IGe9tMbelsWY9JmixktIy1gb4ZSZZaj8UuSfPQ_vU7yUlGtu5hLxZYJxD3oTtJp98R8tGgz7K5Q-VVGY-hqADXQWfiHOmZRv8sQ5WI07N8MoPpZXa5R9jmLUxI2g-QlmGZ3mSHHS8hmLQvvpph0JDE9_vksBA881o9zIfbcxWPeF4ArN_HJLx4YOiODwpQ_Q_Fl3-nSf5xVxpc0PgpebKOHWm_m-0zsmeb5-RRV03y7gX5cR6wYD2OBp3X89os7mjr6Ow0FSlVTUUb285b5GttqPHCXtD5yhcRXlLTxu0NtiNOf9ZX6Njo18HF4AQohrR0ctIfpseM4tq4WNUhK_0lmY1HF8NJvC6lEBuQcBtr9MqJroRNXQUqkygGkwA4ACMzVjnr3XymnZaMpcoKw1UOmVCF4YY7kPwVOWjaxr4h1KKNc6ZMlTMFGnAzXvDKggdvMkawKiKfNswtbzrEjDLcdPOi7ERRoijKIIryPiIDz_8tpUe7Dj_axVW5ln4pmbUiBaFzJkFzpVKplZNOO4Y7skpE5GgjvXJtgsvSPwvPEiaTLCIftt1oPP5GRCHHVx2N8Ih-SPO6E_Z2JrjxxK2cYBEpdtRgZ6q7PU19HQC6Uw_TiOMj8nmjMb_n9W9evP0_8nfkMfNK7dOI2BE5QB2z7zFCutU9si8uBX6L8ZceOez3p-dTbAejs2_fe8FceuHs4RcSIBBR
linkProvider Springer Nature
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1bb9MwFLamTQheEHcCA4wETxA1cZzbw4TWtVNH1wpBK-3N-DqCaFLaVaj7cfw2jp2kU7m97SlS7EjOOcfn4sv3IfRKQszSiQHj5XHk00xR8ING-gn0JwLic-5YIkbjZDCl78_isx30s70LY49Vtj7ROWpVSbtG3rG3fOOA5EH8bv7dt6xRdne1pdDgDbWCOnAQY83FjqFe_4ASbnlw0gN9vybkuD85GvgNy4AvaU4vfAEBKxAq1aFRlMc5jFAGlBpKZR4TZbSNgLEwIick5DqVEU9onPJMRjIy1IIxQQjYo3YBZRftdfvjDx83qzwWfz2jtLmtE0RZZ0mdb7IssjFkP4F_uRURHXHA37LdPw9t_rZz6wLi8R10u8lk8WFtenfRji7voRs1t-X6Pvr6ySHTWlQPPCtmhVyscWXwdBSmIealwqWuZhVouZBYWtNb4NnKUhovsaz8ag7PfoS_FecQZvGwO-n2KIYEGw96h0dhh2Dw1ItV4c7IP0DTaxH5Q7RbVqV-jLAGjxMRLlVCOBVUC6i4laYWSkrKlCgPvWmFy-Y1fgdz--5RxmpVMFAFc6pglx7qWvlvelrsbfeiWpyzZiqznGidhjQVCcmpiDgPc8FNboQhUB-q1EP7rfZY4xCW7Mp8PfRy0wxT2e7PcJD4qu6TWnxB6POoVvZmJFAGQ2GZEg9lW2awNdTtlrL44uDCQwsaCd976G1rMVfj-rcsnvz_N16gm4PJ6JSdnoyHT9EtYg3aHmgi-2gX7Es_g1ztQjxvJgRGn697Dv4CGGtPnw
linkToPdf http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1bb9MwFLamTSBeEHcCYzMSPEHUxHHi5GFC69qqo6yaYJX2FnwdQTQp7SrU_UR-FcdO0qnc3vZUqXEl99xPfPx9CL2SkLN0YsB4eRz5NFUU4qCRfgLriYD8nDmWiJNxMpzQ9-fx-Rb62d6FsWOVbUx0gVpV0r4j79hbvnFAsiDumGYs4rQ3eDf77lsGKXvS2tJp8IZmQR04uLHmksdIr35AO7c4OO6B7l8TMuifHQ39hnHAlzSjl76A5BUIxXRoFOVxBruVAaWGUpnFRBlts2EsjMgICblmMuIJjRlPZSQjQy0wE6SDHQZZHxrBnW5_fPpx_cbHYrGnlDY3d4Io7Syoi1OWUTaGSijwrzayoyMR-Fvl--cA52-nuC45Du6hu01Viw9rM7yPtnT5AN2qeS5XD9HXTw6l1iJ84GkxLeR8hSuDJychCzEvFS51Na1A44XE0prhHE-Xlt54gWXlVzP47Ef4W3EBKRePumfdHsVQbONh7_Ao7BAMUXu-LNy8_CM0uRGRP0bbZVXqpwhriD4R4VIlhFNBtYDuW2lqYaWkZER56E0r3HxWY3nk7gw-SvNaFTmoIneqyK881LXyX6-0ONzui2p-kTdunWdEaxZSJhKSURFxHmaCm8wIQ6BXVMxDu6328iY4LPJrU_bQy_VjcGt7VsNB4st6DbNYg7DmSa3s9U6gJYYmkxEPpRtmsLHVzSdl8cVBh4cWQBJ-76G3rcVc7-vfsnj2_7-xj26DL-Yfjsej5-gOsfZsZ5vILtoG89IvoGy7FHuNP2D0-aZd8BcBwlPj
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Structural+mimicry+of+UM171+and+neomorphic+cancer+mutants+co-opts+E3+ligase+KBTBD4+for+HDAC1%2F2+recruitment&rft.jtitle=Nature+communications&rft.au=Chen%2C+Zhuoyao&rft.au=Chi%2C+Gamma&rft.au=Balo%2C+Timea&rft.au=Chen%2C+Xiangrong&rft.date=2025-04-02&rft.pub=Nature+Publishing+Group+UK&rft.eissn=2041-1723&rft.volume=16&rft.issue=1&rft_id=info:doi/10.1038%2Fs41467-025-58350-z&rft.externalDocID=10_1038_s41467_025_58350_z
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=2041-1723&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=2041-1723&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=2041-1723&client=summon